AVSE vs AVXC

AVSEAAvantis Responsible Emerging Markets Equity ETF

AVXCAAvantis Emerging Markets ex-China Equity ETF

In short

AVSE Avantis's emerging markets workhorse with a values filter bolted on: the same profitability tilt and thousands-of-stocks build as its flagship EM fund, at the same 0.33% fee, minus the issuers its team flags on ESG grounds.

AVXC The China question, answered by subtraction. Avantis runs its usual emerging-markets playbook (roughly 2,800 stocks of every size, tilted toward the cheap and the profitable) with China left out entirely, for 0.33% a year.

Stated mandate

AVSE The fund is an actively managed emerging-markets equity strategy that seeks to identify securities with higher expected returns while excluding issuers that raise concerns under the portfolio team's environmental, social, and governance evaluation.

AVXC The fund invests in a broad set of companies across emerging-market countries, excluding China, and spanning all market capitalizations. It seeks higher expected returns by overweighting securities with lower valuations and higher profitability ratios.

Why people hold it

• AVSE Charges 0.33% a year, roughly half the typical fee among actively managed emerging markets funds. The cost drag stays out of the way of the strategy.
• The screen trims rather than concentrates: the portfolio still spans thousands of emerging markets stocks, not a short list of approved names.avantisinvestors.com
• Active in the Avantis sense: a systematic tilt toward more profitable companies, not a manager's hunches about which stocks pop next.
• Priced level with Avantis's mainstream EM funds (AVEM, AVXC) and JPMorgan's JEMA at 0.33%, and one of the stronger builds in the active EM group.

• AVXC 0.33% a year, about half the typical fee among active EM funds, and the ex-China carve-out costs no more than Avantis charges on its with-China flagship, AVEM.
• Roughly 2,800 holdings spanning all market-cap sizes, so removing China doesn't turn the fund into a concentrated bet on a few large markets.avantisinvestors.com
• Actively run against MSCI Emerging Markets IMI rather than tracking it: the mandate overweights lower-valuation, higher-profitability companies.
• One of the stronger builds in the active emerging-markets group we review, on cost and portfolio construction alike.

Worth knowing

• AVSE Thinly traded next to the index-fund giants of emerging markets, so bid-ask spreads can widen and larger orders need care.
• The ESG exclusions are the portfolio team's own judgment calls, so the holdings and the results will drift from a plain broad EM benchmark.
• Emerging markets equity brings currency swings and country-level political risk, and this fund holds that exposure directly. Pays quarterly.

• AVXC Thinly traded next to the giants of the category, so spreads and limit orders matter more on the way in and the way out.
• Launched in 2024, so the live record is short and the risk picture is still forming.
• Leaving China out is a real departure from standard EM exposure, and the value and small-cap tilts add more distance from a plain cap-weighted index.

Full AVSE profile⁠

Full AVXC profile⁠